Nivolumab With DC Vaccines for Recurrent Brain Tumors

NCT02529072 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Malignant Glioma
Astrocytoma
Glioblastoma

Interventions

DRUG: nivolumab
BIOLOGICAL: DC

Sponsor

Gary Archer Ph.D.

Collaborators

[object Object]
[object Object]